Clinical Trial

A Phase I Dose Finding Study of MB-CART2219.1

Name: A Phase I Dose Finding Study of MB-CART2219.1 — clinical trial record (NCT07108868)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase I dose finding study of MB-CART2219.1 targeting CD19/CD22 in adult and pediatric patients with relapsed/refractory B-cell malignancies

Trial Details

NCT Number	NCT07108868
Lead Sponsor	University Hospital Tuebingen
Conditions	Lymphoma, CLL, Acute Lymphoblastic Leukemia, Pediatric
Enrollment	36 participants
Start Date	2025-06-23
Primary Completion	2027-03 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2025-08-07